TY - CHAP
T1 - Management of Low-Grade Gliomas
AU - Soffietti, R.
AU - Baumert, B.
AU - Bello, L.
AU - Von Deimling, A.
AU - Duffau, H.
AU - Frénay, M.
AU - Grisold, W.
AU - Grant, R.
AU - Graus, F.
AU - Hoang-Xuan, K.
AU - Klein, M.
AU - Melin, B.
AU - Rees, J.
AU - Siegal, T.
AU - Smits, A.
AU - Stupp, R.
AU - Wick, W.
PY - 2011/9/21
Y1 - 2011/9/21
KW - Antiepileptic treatment-no papers dealing with antiepileptic drugs (AEDs), with LGG and seizures
KW - Chemotherapy (PCV or TMZ), initial treatment after surgery-in high-risk patents
KW - Cognitive rehabilitation, salutary effect-on short- and long-term cognitive complaints and mental fatigue
KW - Conventional MRI, for differential diagnosis-biopsy or resection
KW - Low-grade gliomas (LGGs)-group of tumours, clinical, and molecular characteristics
KW - Management of low-grade gliomas
KW - Oligoastrocytomas, on detection-convincing astrocytic and oligodendroglial components
KW - Oligodendrogliomas, cellular-perinuclear halos ('fried egg' or 'honeycomb'pattern)
KW - Seizures, common presentation-partial or generalized
KW - World Health Organization (WHO) classification-grade II astrocytomas, oligodendrogliomas and oligoastrocytomas (Class I)
UR - http://www.scopus.com/inward/record.url?scp=84885541139&partnerID=8YFLogxK
U2 - 10.1002/9781444346268.ch15
DO - 10.1002/9781444346268.ch15
M3 - Chapter
AN - SCOPUS:84885541139
VL - 2
SP - 213
EP - 223
BT - European Handbook of Neurological Management
ER -